Upgrade to SI Premium - Free Trial

Medtronic, Inc. (MDT) PT Raised to $87 at Oppenheimer Following 3Q Report

February 22, 2017 9:23 AM
Oppenheimer raised its price target on Medtronic, Inc. (NYSE: MDT) to $87.00 (from $84.00) while maintaining a Outperform rating.Analyst Steven ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles